Meridian Life Science, Inc.

Meridian Life Science, Inc. is the Life Science division of Meridian Bioscience, a prominent player in the biotechnology and manufacturing industries. Established in 1983 and headquartered in the United States, the company's slogan "Life Discovered. Life Diagnosed." resonates with its core operations as a leading large-scale manufacturer of antibodies, viral antigens, recombinant proteins, PCR enzymes, nucleotides, and critical assay reagents.

For over 30 years, Meridian has been at the forefront of providing innovative life science solutions and building trusted partnerships. The company's focus on offering products and services that advance the development of diagnostic assays is underscored by its extensive capabilities and services, which include commercial scale manufacturing of antigens and antibodies, full line of immunoassay reagents, large scale production of reagents for molecular assays, technical support with assay development experience, and dedicated R&D and manufacturing teams. Additionally, Meridian offers robust and mature quality, contract R&D, process development, and manufacturing services to the in vitro diagnostic markets.

The company's offerings span across various segments such as immunodiagnostics, antigens & antibodies, recombinant proteins, blocking reagents, and contract services, including cell & viral banking, PCR amplification, nucleotides, enzymes, and PCR/qPCR reagents.

As of now, there is no publicly disclosed information available regarding the last investment or the investors for Meridian Life Science, Inc. This indicates a potential opportunity for venture capital firms or investors interested in the biotechnology and manufacturing sectors to explore collaboration and investment prospects with this established and forward-thinking organization.